$7.78
1.17% yesterday
Nasdaq, Jun 06, 09:49 pm CET
ISIN
CA60255C1095
Symbol
MNMD
Sector
Industry

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock price

$7.79
+1.48 23.45% 1M
+0.35 4.70% 6M
+0.83 11.93% YTD
+0.58 7.97% 1Y
+2.45 45.96% 5Y
-19.15 71.08% 10Y
-19.15 71.08% 20Y
Nasdaq, Closing price Fri, Jun 06 2025
+0.10 1.30%
ISIN
CA60255C1095
Symbol
MNMD
Sector
Industry

Key metrics

Market capitalization $588.56m
Enterprise Value $398.15m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 2.64
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-111.33m
Free Cash Flow (TTM) Free Cash Flow $-91.95m
Cash position $212.44m
EPS (TTM) EPS $-0.91
P/E forward negative
Short interest 15.34%
Show more

Is Mind Medicine Inc - Ordinary Shares (Sub Voting) a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Mind Medicine Inc - Ordinary Shares (Sub Voting) forecast:

10x Buy
100%

Analyst Opinions

10 Analysts have issued a Mind Medicine Inc - Ordinary Shares (Sub Voting) forecast:

Buy
100%

Financial data from Mind Medicine Inc - Ordinary Shares (Sub Voting)

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 31 31
21% 21%
-
- Research and Development Expense 82 82
56% 56%
-
-111 -111
20% 20%
-
- Depreciation and Amortization 0.50 0.50
83% 83%
-
EBIT (Operating Income) EBIT -111 -111
17% 17%
-
Net Profit -78 -78
38% 38%
-

In millions USD.

Don't miss a Thing! We will send you all news about Mind Medicine Inc - Ordinary Shares (Sub Voting) directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock News

Positive
The Motley Fool
3 days ago
Mind Medicine (MNMD 2.81%), a healthcare company that's looking to develop treatments based on psychedelic compounds, was something of a sleeper stock in May. Several positive developments pushed the highly specialized enterprise's share price higher, to the point where it closed the month up almost 14% in price.
Neutral
Business Wire
10 days ago
NEW YORK--(BUSINESS WIRE)---- $MNMD--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company's management team will participate in the following investor conferences: Jefferies Global Healthcare Conference Format: Pres...
Neutral
Business Wire
11 days ago
NEW YORK--(BUSINESS WIRE)---- $MNMD--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the appointment of Brandi L. Roberts as its Chief Financial Officer (CFO), effective June 2, 2025. In her new role, Ms. Roberts will join MindMed's exec...
More Mind Medicine Inc - Ordinary Shares (Sub Voting) News

Company Profile

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The firm develops a non-hallucinogenic version of the psychedelic ibogaine. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn in 2019 and is headquarter in New York, NY.

Head office Canada
CEO Robert Barrow
Employees 74
Founded 2019
Website mindmed.co

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today